FGFR4 and hepatocellular carcinoma: Following that, we grouped the patients, investigated the variations in gene pathway levels between patients with high FGFR4 expression and those with low expression in HCC, and concluded that FGFR4 may be employed as a major marker target for predicting and treating HCC.